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Background: In this study, the reliability of perimetric contrast sensitivity 
measurements favouring the achromatic, the red-green and the blue-yellow 
postreceptorial mechanisms was analysed.  
Methods: A new technique, multichannel ATD perimetry, provides spatial 
and temporal stimuli favouring the detection by an achromatic mechanism (A), 
from a magno or parvocellular origin, or by a red-green (RG) chromatic 
mechanism, with a parvocellular origin, or a blue-yellow (BY) mechanism, with a 
koniocellular origin. The repeatability and reproducibility of contrast sensitivity 
measurements with these stimuli were studied in a group of 40 healthy subjects. 
The analysis was carried ut on 21 testing points within a 60ºx40º fovea-
centered region of the visual field.  
Results: The within-observer repeatability for the four mechanisms 
studied is either good or excellent when the Intra-Class Correlation Coefficient 
(ICC) can be calculated. For the remaining points, the Friedman’s test finds that 
the measurements are repeatable. The between-observer reproducibility was 
either excellent or good in cases where the ICC applied and according to the 
Friedman’s test all results were reproducible.  
Conclusions: The results obtained showed good repeatability and 
reproducibility with achromatic, red-green and blue-yellow stimuli, although with 
BY stimuli repeatability is slightly worse. Future studies on the diagnostic 
validity of this device, are based on the fact that changes of sensitivity can be 
compared by means of a visual single task, contrast sensitivity measurement, 
and using a common metric. 
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The diagnosis of alterations of the visual system at an early stage is one 
of the main objectives pursued by vision researchers. Early detection could stop 
the loss of visual capabilities– even if not at present, maybe in the future, as 
increasingly effective treatments are being developed- or at least minimize the 
negative effects that some treatments produce. 
It has been shown that diseases affecting visual function can damage the 
mechanisms involved in spatial, chromatic and motion processing1, causing 
losses in contrast sensitivity both with stationary2 and moving3 stimuli, 
increasing thresholds in dark adaptation4 and provoking either generalized 
colour contrast sensitivity losses or specific losses along the blue-yellow or de 
red-green axes. Furthermore, congenital and acquired defects, caused by 
diseases, medications or unhealthy habits, influence colour perception and 
contrast sensitivity. For instance, losses in the chromatic or achromatic 
mechanisms, or in both, have been reported in glaucoma1,5-8, ocular 
hypertension9,  optical neuritis10, AMD (Age-related Macular Degeneration)11,  
diabetes2-4,12,13, multiple sclerosis10, or  Parkinson’s disease14.  
The perimetry tests more frequently used to diagnose and evaluate 
losses of visual function are SAP perimetry (measurement of luminance 
thresholds with white-on-white stimuli), SWAP (measurement of the luminance 
thresholds to detect a blue stimulus against a yellow background) and FDT 
(contrast thresholds with spatio-temporal achromatic stimuli). Both SWAP13, and 
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FDT15 perimetry seem capable of detecting functional damage in different 
regions of the visual field before other characteristic symptoms of certain 
diseases appear. For example, detection of damage in 10 to 30% of 
hypertensive subjects16 and in 33.3% of subjects with suspected optic nerve 
damage with SWAP has been reported17. A more specific test for the 
parvocellular pathway, the high-resolution perimetry (HPRP), detects damage in 
15 to 24% of hypertensive subjects16. Nowadays, to assess different visual 
mechanisms of a patient, it is necessary to use a combination of devices. For 
example, FTD perimetry to analyze the magnocellular pathway18,19, HPRP to 
analyze the parvocellular pathway20,21 or SWAP perimetry for the koniocellular 
pathway22,23. This identification of visual tasks with particular cellular pathways 
is perhaps too simplistic (we refer the interested reader to Kaplan24) and it is not 
always clear how well a given technique isolates the responses of a particular 
mechanism. See, for instance, White et al.25 for a discussion about the relative 
contributions of the magno and parvo pathways in the detection of FDT stimuli. 
In the case of the blue-yellow mechanisms, although other cells with S-cone 
input might mediate an S-off pathway26,27, they represent a very small 
percentage of the total population of cells with S-cone input28, and their role in 
detection tasks and in colour appearance is not clear at present. But admitting 
that these different techniques do indeed favour different mechanisms, we find 
that neither the tasks carried out by the patient nor the metrics used to express 
the results are comparable, making the analysis of the relative losses incurred 
by each mechanism difficult. In addition, commercial devices limit the capability 
of the user to configure the spatial-temporal and chromatic characteristics of the 
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stimuli to adapt the design to particular aims of study –although recent efforts 
have been made to overcome this limitation29. For these two reasons, it would 
be desirable to have a device with stimuli that could be configured to focus on 
different visual pathways. In order to improve the performance of existing 
diagnostic technologies, the Vision Group of the University of Valencia has 
developed a new multichannel contrast sensitivity perimetry technique named 
“ATD Multichannel Functional Test”30. A, T and D stand in different colour vision 
models for the three post-receptorial mechanisms, “achromatic” (A), “red-green” 
(because this is the colour mechanism left to Tritanopes, hence the T) and 
“blue-yellow” (because this is the colour mechanism left to Deuteranopes, 
hence the D). Since this notation is not usual in clinical research, we will use in 
what follows RG and BY instead when referring to the chromatic mechanisms. 
The examiner may define stimuli in the desired directions in colour space31,32 
and choose the spatial and temporal frequency of the stimulus to favour a 
particular mechanism (for example, magno or parvo when using achromatic 
stimuli) while ensuring that the same task is performed by the patient for each 
stimulus modality (see Appendix). This feature is essential in the process of 
searching for the optimal stimulus to detect and evaluate damage caused by a 
given pathology. For instance, in a recent study we have shown that chromatic 
red-green and blue-yellow patterns with low spatial (0.5 cpd) and temporal (2 
Hz) frequencies could be more sensitive for early detection of glaucomatous 
damage than achromatic patterns, including low spatial-high temporal frequency 
doubling stimuli (FDT perimetry)33,34.  
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The aim of our study is to demonstrate the reliability of the 
psychophysical procedure used, assessing the repeatability and reproducibility 
of the measurements made with our technique/device. The precision of a device 
or clinical method is a factor that should be considered when conducting 
method comparison studies. If a device has poor precision it is unlikely to have 
good agreement with another device. Hence, comparing the precision of the two 
devices or methods will provide greater insight into the source of eventual 
differences. Repeatability and reproducibility are the two sides of precision35. 
Repeatability refers to the variability in repeated measurements by one subject 
when all other factors are assumed constant (within-observer variability). 
Reproducibility refers to the variability in repeated measurements when one or 
more factors, such as observer, instrument, calibration or time is varied 
(between-observer variability). In this paper, the changing factor is the clinician 
conducting the test.  
 
METHODOLOGY 
1. Device 
The ATD multichannel perimetry provides spatial and temporal stimuli for 
determining contrast sensitivity measurements at different testing points in the 
visual field, using a staircase psychophysical method. To evaluate the 
achromatic mechanism A, a stimulus favouring the magnocellular pathway (A-
0.5cpd/12Hz) and other stimulus stimulating the parvocellular pathway (A-
4cpd/2Hz) were chosen. A large corpus of literature shows that the appearance 
of spatio-temporal patterns at detection threshold depends on the ratio between 
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temporal and spatial frequency. Though frontiers are not sharply defined, 
observers perceive either the temporal or the spatial pattern of the stimulus at 
threshold, depending on whether the frequency ratio is either above 1-2 
degrees/second or below this value36-40. According to the prevalent theory 
linking visual functions and visual pathways (see again Kaplan28), this result 
would imply that detections would be mediated either by the magno or by the 
parvo pathway, respectively. Our choice of stimuli is also supported by 
experiments on selective lesions, which show that damage in the parvo 
pathway greatly impairs the detectability of gratings in all the spatio-temporal 
domain, except for the high temporal-low spatial frequency corner, and the 
contrary happens when damage is confined to the magnocellular pathway41-43. 
It is not possible, however, to ensure that the parvo pathway does not contribute 
to the detection of the A-0.5cpd/12Hz stimuli (see Anton et al.34 for a 
discussion). The red-green and blue-yellow chromatic mechanisms, putatively 
mediated by the parvo and koniocellular pathways, respectively, were evaluated 
by stimuli modulated along the RG and BY directions of color space, with a 
spatial frequency of 0.5cpd and a temporal frequency of 2Hz (RG-0.5cpd/2Hz 
and BY-0.5cpd/2Hz). The choice of these stimuli fulfilled two conditions: first, 
the dynamic range of the device still allowed the measurement of the subject’s 
threshold44 and second, the differences between normal and glaucomatous 
patients were the largest we had obtained with our device34. For a more detailed 
explanation of the stimuli used, see the Appendix and Anton et al.34. 
 
Measurement procedure 
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Measurements were carried out in a darkened room. During a session, 
contrast sensitivity was measured at the 21 testing points described in the 
Appendix. The screen is placed at 25 cm from the patients and therefore a 4.00 
D lens was added to their refraction to avoid accommodation. After an 
adaptation period of 30 seconds, the fixation stimulus flickered to signal the 
beginning of the test and the first trial was presented. The subject was 
instructed to press a button if any variation from the background was detected 
at any point of the visual field. Subjects’ responses caused the stimulus to 
disappear from the display but counted as detections only if they occurred 100 
ms after stimulus onset and before stimulus offset. The maximum duration of 
the stimulus was 1 second. The time interval between trials was randomized by 
the program, from 200 to 500 ms, to minimize the likelihood that subjects would 
engage in rhythmic responses.  
Thresholds were determined by an interleaved stepwise threshold 
algorithm. At each trial, the testing point was changed at random. In the first trial 
at a given testing point, the stimulus had the maximum amplitude achievable by 
the CRT. If this stimulus was detected, amplitude was divided by 2 at the next 
trial at that point, and continued decreasing in this way until the subject failed to 
detect the stimulus. The staircase was then reversed and amplitude increased 
by a  factor for the next presentation and continued increasing in this way 
until the test was again detected. This triggered a second reversal, and 
amplitude was divided by , and so on. Thus, the amplitudes (see Appendix) 
at two consecutive trials at the same region, ∆Rk-1 and ∆Rk, relate to each other 
as follows (Equation 1): 
2
4 2
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 (1) 
 
where n is the number of reversals until trial k. The criteria for exiting the 
staircase procedure at a given point were either totaling four reversals or 20 
presentations, whatever came first. The staircase was also interrupted at a 
given point if a series of 5 consecutive stimuli with maximum amplitude passed 
undetected. Once a staircase was finished, threshold at that point, ,  was 
defined as the amplitude value of the last detected stimulus. If no stimulus was 
detected, threshold was defined as the maximum amplitude value achievable by 
the device in the corresponding cardinal direction. Contrast sensitivity in 
decibels (dB) was computed as (Equation 2): 
 
 (2) 
where  is the maximum generable amplitude along the direction of the 
stimulus.  
 
Control stimuli 
Among the stimuli presentations, up to 16 false positive trials and 10 
false negative trials were also randomly interleaved. Additionally, each session 
included up to 8 fixation-losses catch trials, presentations in the blind spot 
location previously estimated for the subject. These are 1.5ºx1.5º squares with 
the same chromatic and spatial modulation as the false negative trials 
n
n
kk
RR
2
)1(
)(log)(log
1
122
+
−
−
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R∆
thres
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∆
=
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(achromatic with fx=2 cpd, without flicker), with maximum amplitude. Test results 
were rejected if either the false positive or the false negative rate was over 33%, 
or if fixation losses surpassed 20%. 
 
2. Selection of subjects  
We worked with a group of 40 healthy subjects aged between 20-35 and 
measures were taken in one eye randomly chosen. The ocular and medical 
history of the participants was examined, to discard those subjects with 
symptoms or familiar antecedents of visual or systemic diseases affecting 
vision. Preliminary tests included refraction, assessment of the anterior ocular 
segment with a Topcon SL8Z Biomicroscope and of the posterior segment with 
a Topcon TRC-NW6S Non-Mydriatic Retinal Camera, non-contact tonometry 
with AT900®-Haag-Streit and the Farnsworth-Munsell 100-Hue colour-test. 
Inclusion criteria were absence of ocular and systemic diseases that could 
affect vision, intra-ocular pressure (IOP) values below 21 mm Hg, spherical 
equivalent below 4D and cylinder below 2D, 20/25 Snellen visual acuity or 
better and normal chromatic discrimination as assessed by the Farnsworth-
Munsell100-Hue test. The study adheres to the tenets of the Declaration of 
Helsinki for Research Involving Human Observers. 
 
3. Experimental design and development of the measurement 
sessions  
The 40 subjects were divided into two groups of 20 subjects each. Group 
1 underwent testing with stimulus A-0.5cpd/12Hz and A-4cpd/2Hz, to evaluate, 
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respectively, the achromatic mechanisms of magnocellular and parvocellular 
origin (in what follows, A-Magno and A-Parvo for short). Group 2 underwent 
testing for the red-green (RG-0.5cpd/2Hz) and blue-yellow (BY-0.5cpd/2Hz) 
chromatic mechanisms (in what follows RG and BY for short).  
Each subject underwent four perimetry tests with each of the two 
stimuli assigned to their group: three perimetry tests were conducted by 
Clinician 1 and one by Clinician 2. Data measured by Clinician 1 was used in 
the repeatability study, the comparison between Clinicians 1 and 2 constituted 
the reproducibility study. Tests took place on different days to avoid the 
influence of fatigue. In the first day, the preliminary tests to determine whether 
the subject met the inclusion criteria were carried out and the subject performed 
the four perimetry tests for each of the two stimuli assigned to his/her group in 
two different days. The first two tests were conducted by Clinician 1, in the two 
last ones Clinicians 1 and 2 alternated in random order. In this way, we 
expected to reduce possible learning effects in the reliability study. 
Each perimetry test took about 4 to 8 minutes, depending on the 
subject and on the stimulus characteristics (A-Magno: 7.7±0.7 min, A-Parvo: 
4.1±0.6 min, RG: 4.9±0.4 min, BY: 5.7±0.4 min). The subject rested for 10 
minutes between perimetry tests and the duration of a complete measurement 
session was always kept below one hour.  
 
4. Statistical analysis  
The statistical tests were performed using SPSS v. 14.0.1 for Windows 
(SPSS Inc., Chicago, IL, USA). Besides analyzing the results obtained at the 
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different testing points, we have considered groupings in three zones: the fovea 
(point 11, see Table 1), the perifovea, which comprises the four points 
surrounding the fovea (points 8, 9, 13 and 14) and the extrafovea (remaining 
points). 
The study of the reliability of our device follows the guidelines laid out by 
the International Organization for Standardization (IOS) and we have adopted 
their definitions of repeatability and reproducibility35. In the literature on 
automated perimetry reliability with normal subjects, a great variety of 
methodologies is used, but the IOS guidelines are not followed45-47. The 
normality of the samples was evaluated using the Shapiro-Wilk test at the 95% 
significance level, as recommended for samples with less than 30 subjects, and 
the appropriate parametric or non-parametric tests applied in consequence48-50. 
For normally distributed data, the concordance-coincidence between 
multiple measures of the same variable was assessed with the Intraclass 
Correlation Coefficient (ICC)51, both in the study of within-observer concordance 
(repeatability) and in the study of between-observer concordance 
(reproducibility). According to the value of this coefficient, measurement 
reliability is labelled as: absent (0), low (<0.4), between regular and good ([0.4-
0.75]) and excellent (> 0.75)51. 
Friedman’s nonparametric test of k-related samples was carried out if the 
distributions were not normal. An asymptotic significance greater than 0.05 with 
this test indicates that there are not significant differences between the 
measurements, that are therefore considered repeatable or reproducible48,49,52. 
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RESULTS  
Mean sensitivity values for each stimulus are summarized at Tables 1 
and 2. It can be seen that the A-Magno mechanism has the highest values of 
sensitivity for all points, followed by the BY mechanism. On the contrary, the A-
Parvo mechanism has very low values of sensitivity, except in the fovea and the 
perifovea. The RG mechanism shows the highest sensitivity averages in the 
fovea and perifovea and some points of the extrafovea (4, 5, 17, 18), but the 
values are always lower than those of the A-Magno mechanism. Sensitivity 
determines the mean number of trials (MNT) needed to measure threshold,   
therefore MNT decreases with eccentricity and is in general greater for the A-
Magno and BY stimuli than for RG and A-Parvo. The limit of 20 presentations is 
only occasionally reached with certain subjects at random locations with the A-
Magno stimulus, hardly 5% of the total number of measurements. 
From the measures of sensitivity in the four mechanisms (A-Magno, A-
Parvo, RG and BY) the repeatability of the instrument and the concordance 
between results from the two clinicians were analysed. 
 
1. Within-observer Repeatability  
The results of the repetability analysis for our four stimuli are 
summarized in Table 1. There appears the mean and the standard deviation of 
the sensitivity, and either the ICC values or the p-value of Friedman’s test, as 
appropriate. Figure 1 presents the point-by-point repeatability classification for 
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each of the four mechanisms. In this figure, the visual field has been divided in 
10ºx10º regions, centered in each of the testing points. 
Insert Figure 1 here 
In the A-Parvo mechanism, sensitivity data at most points at the 
extrafovea (76%) present non-normal distributions. All these measurements are 
repeatable according to the Friedman’s test. Fovea and perifovea present 
normal distributions and the repeatability is excellent in all cases (see ICC 
value). In the A-Magno mechanism, most of the points present normal 
distributions with repeatability between excellent (67%) and good (19%). At the 
perifovea, which does not follow the normal distribution (14%), within-observer 
measurements are repeatable. In the RG mechanism, most points present a 
normal distribution and the repeatability is excellent (62%), with a reduced 
number that are rated as just good (14%). In all cases where the distribution is 
not normal (24%), the Friedman’s test proves that the measures are repeatable. 
In the BY mechanism most data distributions are normal, and the ICC values 
show that repeatability is excellent (38%) or good (48%). For points with non-
normally distributed data (14%), the results are repeatable in all cases. 
In summary, within-observer repeatability for the four mechanisms 
studied is either good or excellent when the ICC can be calculated. For the rest 
of points, the Friedman’s test finds that the measurements are repeatable.  
 
2. Between-observer Reproducibility  
To check the reproducibility, we compared two measurements 
supervised by different clinicians. The third perimetry test of Clinician 1 was 
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compared with the single measurerement performed by Clinician 2. As in the 
previous study, the normality of the sensitivity distributions was analysed and 
the appropriate reliability test for each case was applied. The results are shown 
in Table 2, using the same criteria as in Table 1. In Figure 2 presents the point-
by-point reproducibility classification of for each of the four mechanisms. 
Insert Figure 2 here 
In the A-Parvo mechanism, most points in the extrafovea follow non-
normal distributions, and all points have proved to be reproducible according to 
the Friedman’s test. As in the previous section, the distributions are normal in 
fovea and perifovea and reproducibility is excellent at all testing points. In most 
testing points, data from the A-Magno mechanism follow normal distributions 
with reproducibility between excellent (48%) and good (19%). In comparison 
with the data presented in the within-observer study, a larger number of 
extrafoveal points but just one at perifovea (up to a total of 33%) do not follow 
the normal distribution. Friedman’s analysis indicates that all the measurements 
are reproducible. With the RG stimulus, most points follow the normal 
distribution and reproducibility results are either excellent (52%) or good (24%). 
In all cases where the distribution is not normal (24%), the Friedman’s test 
indicates that the measurements are reproducible. With regard to the BY 
stimulus, most of the data distributions are normal, and the ICC test results are 
either excellent (38%) or  good (48%). In the regions with non-normal 
distributions (24%), the result is always reproducible. 
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In summary, the between-observer reproducibility was either excellent 
or good in cases where the ICC applied and according to the Friedman test all 
results were reproducible.  
 
DISCUSSION  
A study of the reliability of the multichannel perimeter has been designed 
for the A-Magno, A-Parvo, RG and BY mechanisms. A sample of 40 normal 
subjects divided in two groups have participated in this study. All the subjects 
carried out four repeated perimetry tests, three under the supervision of a 
clinician (within-observer study) and one under the supervision of a different 
clinician (between-observer study). We have found that the within-observer 
measures are repeatable, i.e. there is no significant variability in the repetition of 
the measurements of an subject when other factors remain constant. In the 
between-observer study we have concluded that the measurements conducted 
by both clinicians are interchangeable. 
In general, almost all measurements follow a normal distribution of the 
responses for all mechanisms. The points where sensitivity data are not 
normally distributed do not seem to follow a systematic pattern, common to all 
the stimuli, such as a dependence on eccentricity. The sole exception is the A-
Parvo stimulus, which does not follow the normal distribution in the majority of 
the points, possible due to the subjects’s low sensitivity outside the perifovea. 
However, in the fovea and the perifovea the distribution of responses follows the 
normal distribution. 
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It is difficult to compare our reliability study with the literature, due to 
differences in the reliability criteria and in the number of measurements, in the 
structure of a measurement session and in the factors that change between 
measurements45-47. In spite of this, we may conclude that our multichannel 
perimeter presents standard deviation values similar to other studies with 
different devices and furthermore, our precision (ICC) results are as good as 
those obtained in other types of perimeter46,47. 
The reasons for this good performance may lie in the psychophysical 
measurement procedure used and in the comparatively reduced number of 
points tested in the visual field. It has been shown that measurement 
repeatability depends on a large number of factors: number of testing points in 
the visual field and number of stimulus presentations in the measurement 
procedure45,47,53,54, the spatio-temporal characteristics of the stimulus45,53,54, the 
patient’s sensitivity (determined either by eccentricity53, age47,53 or by damage in 
the visual system46),  previous experience53,55, and so on... The four tests we 
have analysed have in common the distribution of testing points, the task to be 
performed by the observer and the psychophysical method, and therefore 
potential differences in repeatability must arise from the stimulus characteristics 
–which determine sensitivity, for instance, and therefore the number of trials 
needed to determine threshold, another relevant factor- or from the different 
limitations that the dynamic range of the device sets in each direction of colour 
space. The analysis of our results becomes complicated by the fact that there is 
not a common metric for repeatability for all testing points, and whereas ICC 
grades the results, the Friedman test doesn’t. Considering only those testing 
Page 17 of 38
Clinical and Experimental Optometry
Clinical and Experimental Optometry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review
18 
 
 
points where the ICC could be computed, we used a general linear model to 
determine which variables determined repeatability and reproducibility.  ICC 
was the dependent variable, mean sensitivity of the population sample, 
eccentricity, and mean number of trials needed to determine threshold –which 
changed with location in the visual field and stimulus type- were the 
independent variables and stimulus type was a factor. The analysis showed that 
the only significant difference was with stimulus type (σ<0.001) and that 
repeatability results were significantly worse for the blue-yellow stimulus. 
Comparisons between SAP and SWAP perimetry also show that repeatability 
with blue-yellow stimuli is worse53. In the between-observer study, ICC did not 
significantly depend on any of the variables listed above. 
We have shown, therefore, that the accuracy of the device, in general, is 
good, although it must still be shown that the same good results hold with an 
older population sample. The study with older adults is necessary and is at 
present a work on progress. Data from glaucoma and OHT subjects that we 
have previously published33 suggest that the A-4cpd/2Hz stimulus is likely to be 
the least useful of the four we have studied in this paper. The potential great 
advantage of this device is the versatility in designing visual stimulus, which 
allows a variety of studies based on the cells/mechanisms involved in the 
detection, which could help to find optimal stimuli for detecting and monitoring 
visual damage. For instance, it has been recently shown that chromatic red-
green and blue-yellow patterns with low spatial (0.5 cpd) and temporal (2 Hz) 
frequencies could be more sensitive for early detection of a glaucomatous 
damage than achromatic patterns, including low spatial-high temporal frequency 
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doubling stimuli (FDT perimetry)34. Moreover, these stimuli detected damage in 
ocular hypertensive and glaucoma suspect patients33,34. These results are 
promising for future use of the device for the early detection of pathologies that 
affect the visual system, when the relevant normative database of the normal 
population has been completed.  
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Table 1: Results from the within-observer study. Mean sensitivities (dB) obtained in three measurements with Clinician 1, with 
their standard deviation (SD) and the results of the repeatability test (Friedman’s p-value or ICC) in each mechanism, at each 
of the 21 testing points in the visual field. (x,y) are the spatial coordinates of each point, in degrees, referred to a coordinate 
system with origin in fovea. 
  A-Parvo A-Magno RG BY 
Point (x,y) mean ± SD (dB) FRIEDMAN ICC 
mean ± SD 
(dB) 
FRIEDMAN ICC 
mean ± SD 
(dB) 
FRIEDMAN ICC 
mean ± SD 
(dB) 
FRIEDMAN ICC 
1 (-25,5) 0.04 ± 0.22 0.36  11.3 ± 3.1  0.91 0.3 ± 0.5 0.85  4 ± 2.1  0.84 
2 (-25,-5) 0.15 ± 0.54 0.06  11.2 ± 3.4  0.94 0.4 ± 1 0.83  4.2 ± 1.9  0.86 
3 (-15,15) 0.1 ± 0.3 0.06  13.1 ± 1.8  0.83 0.4 ± 0.7 0.35  5.6 ± 1.8  0.79 
4 (-15,5) 1.3 ± 1.4 0.51  14.2 ± 1.4  0.9 4.6 ± 1.4  0.86 8.3 ± 1.2  0.63 
5 (-15,-5) 1.2 ± 1.5 0.1  15.3 ± 1.6  0.62 4.8 ± 1.3  0.9 8.4 ± 1.8  0.71 
6 (-15,-15) 0.2 ± 0.7 0.9  12.6 ± 3.3  0.93 1 ± 1  0.9 6 ± 1.6  0.7 
7 (-5,15) 1.8 ± 2.3 0.62  14.1 ± 1.8  0.77 2.2 ± 1.3  0.88 7 ± 1.8  0.48 
8 (-5,5) 5.3 ± 3.6  0,95 16.4 ± 2.4 0.25  8 ± 1.6  0.8 8.7 ± 1.8 0.08  
9 (-5,-5) 4.6 ± 3.3  0,92 16.3 ± 2 0.41  7.9 ± 1.4  0.8 8.8 ± 1.7  0.6 
10 (-5,-15) 1.3 ± 1.5 0.6  14 ± 2.7  0.92 3.5 ± 1.2  0.85 7.2 ± 1.8  0.56 
11 (0,0) 8.3 ± 3.5  0,9 18 ± 2.4  0.55 10.8 ± 2.2  0.71 9.6 ± 1.7  0.76 
12 (5,15) 1.2 ± 1.9 0.07  13.4 ± 2  0.77 1.9 ± 1.4  0.84 5.9 ± 1.9  0.68 
13 (5,5) 5.2 ± 3  0,89 16.8 ± 2.1 0.35  8.3 ± 1.7  0.54 9 ± 1.6  0.65 
14 (5,-5) 5.3± 3.1  0,81 16.9 ± 1.2  0.69 8.3 ± 1.5  0.64 9.1 ± 1.8 0.82  
15 (5,-15) 1.7 ± 2.4 0.06  14.4 ± 3.2  0.92 4.4 ± 1.5 0.54  7.6 ± 1.4 0.07  
16 (15,15) 0.1 ± 0.5 0.46  13.6 ± 1.3  0.87 0.7 ± 0.8 0.21  5.4 ± 1.6  0.8 
17 (15,5) 1.1 ± 1.6 0.25  14.6 ± 1.4  0.81 4.2 ± 1.5  0.82 6.7 ± 1.7  0.72 
18 (15,-5) 1.4 ± 2 0.26  14.9 ± 2.1  0.59 4.8 ± 1.4  0.81 7.3 ± 1.9  0.71 
19 (15,-15) 0.5 ± 1 0.26  13.8 ± 3.5  0.97 2.7 ± 1.3  0.84 6 ± 2  0.79 
20 (25,5) 0.2 ± 0.4 0.05  13.2 ± 3  0.88 1.8 ± 1.4  0.83 5.2 ± 2.6  0.84 
21 (25,-5) 0.2 ± 0.5 0.33  12.5 ± 3.4  0.97 2 ± 1.5  0.77 4.8 ± 2.5  0.93 
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Table 1: Results of the between-observer study. Mean sensitivities (dB) obtained in two measurements with two different 
clinicians, their standard deviation (SD) and the results of the reproducibility test (Friedman’s p-value or ICC) in each 
mechanism, at each of the 21 testing points in the visual field. (x,y) are the spatial coordinates of each point, in degrees, 
referred to a coordinate system with origin in fovea. 
 
 
A-Parvo A-Magno RG BY 
Point (x,y) 
mean ± SD  
(dB) 
FRIEDMAN ICC 
mean ± SD 
(dB) 
FRIEDMAN ICC 
mean ± SD 
(dB) 
FRIEDMAN ICC 
mean ± SD 
(dB) 
FRIEDMAN ICC 
1 (-25,5) 0.05 ± 0.2 0.32  11.3 ± 2.8 0.49  0.3 ± 0.5 0.41  3.8 ± 2.1 0.15  
2 (-25,-5) 0.2 ± 0.6 0.18  11 ± 3.3 0.25  0.4 ± 0.9 0.65  4.1 ± 1.8  0.75 
3 (-15,15) 0.05 ± 0.2 0.56  13.2 ± 2 0.37  0.4 ± 0.7 1  5.6 ± 1.2  0.77 
4 (-15,5) 1.2 ± 1.3 1  15.4 ± 1.5  0.75 4.7 ± 1.3  0.8 8.2 ± 1.1  0.78 
5 (-15,-5) 1 ± 1.4 0.8  15.2 ± 1.7  0.6 4.9 ± 1.3  0.8 8.3 ± 1.4  0.54 
6 (-15,-15) 0.2 ± 0.9 0.31  12.6 ± 3.4 0.46  1 ± 0.9 0.56  5.9 ± 1.7  0.51 
7 (-5,15) 1.8 ± 2.1 1  14.4 ± 1.7  0.75 2.3 ± 1.4  0.8 7.1 ± 1.6  0.63 
8 (-5,5) 5 ± 3.6  0.75 16.3 ± 2.8  0.77 8 ± 1.8  0.6 8.5 ± 2  0.66 
9 (-5,-5) 4.2 ± 3.3  0.9 16.1 ± 2.3  0.8 7.9 ± 1.4  0.7 8.7 ± 1.7  0.7 
10 (-5,-15) 1.1 ± 1.6 1  14.1 ± 3  0.78 3.4 ± 1.4  0.9 7.1 ± 1.8  0.68 
11 (0,0) 8 ± 3.4  0.75 18 ± 2.7  0.85 10.6 ± 2.3  0.8 9.6 ± 1.7  0.85 
12 (5,15) 1 ± 1.7 0.29  13.4 ± 2.3  0.5 2 ± 1..5  0.8 5.8 ± 1.9  0.7 
13 (5,5) 4.9 ± 2.9  0.9 16.6 ± 2.3 0.25  8.3 ± 1.8  0.8 8.9 ± 1.7  0.6 
14 (5,-5) 4.9 ± 3  0.75 16.8 ± 1.2  0.7 8.1 ± 1.6  0.6 9 ± 1.8  0.7 
15 (5,-15) 1.4 ± 2 0.46  14.3 ± 3.3  0.77 4.5 ± 1.4  0.6 7.5 ± 1.5  0.71 
16 (15,15) 0.1 ± 0.3 0.66  13.5 ± 1.3  0.78 0.7 ± 0.9 0.13  5.3 ± 1.4 0.63  
17 (15,5) 1 ± 1.5 0.56  14.4 ± 1.5  0.6 4.3 ± 1.5  0.9 6.3 ± 1.7  0.78 
18 (15,-5) 1.4 ± 1.9 0.62  14.7 ± 2.5  0.85 4.8  ± 1.4  0.9 7.1 ± 2.1  0.8 
19 (15,-15) 0.5 ± 1 0.32  13.8 ± 3.5 0.79  2.7 ± 1.4  0.9 6 ± 2 0.43  
20 (25,5) 0.1 ± 0.3 0.56  13 ± 3  0.81 2 ± 1.4  0.84 2.5 ± 2.5  0.95 
21 (25,-5) 0.2 ± 0.4 0.41  12.4 ± 3.5 0.65  2.1 ± 1.6  0.6 4.5 ± 2.4  0.95 
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FIGURE LEGENDS 
 
Figure 1: Results from the repeatability (within-observer) study for each of the 21 
testing points in the visual field, for our four stimuli (A-Parvo, A-Magno, RG and 
BY).  The visual field appears divided in 10ºx10º regions, centered on each 
testing points, which are coded according to the ICC value or to the result of the 
Friedman test, as appropriate.  ICC: excellent (dark gray), good (light gray). 
Friedman test: repeatable (white).  
 
Figure 2: Results from the reproducibility (between-observer) study for the 21 
testing points in the visual field, four our four stimuli (A-Parvo, A-Magno, RG and 
BY). The visual field appears divided in 10ºx10º regions, centered on each 
testing points, which are coded according to the ICC value or to the result of the 
Friedman test, as appropriate.  ICC: excellent (dark gray), good (light gray). 
Friedman test: reproducible (white). 
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Results from the repeatability (within-observer) study for each of the 21 testing points in the visual field, for 
our four stimuli (A-Parvo, A-Magno, RG and BY).  The visual field appears divided in 10ºx10º regions, 
centered on each testing points, which are coded according to the ICC value or to the result of the Friedman 
test, as appropriate.  ICC: excellent (dark gray), good (light gray). Friedman test: repeatable (white).  
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Results from the reproducibility (between-observer) study for the 21 testing points in the visual field, four 
our four stimuli (A-Parvo, A-Magno, RG and BY). The visual field appears divided in 10ºx10º regions, 
centered on each testing points, which are coded according to the ICC value or to the result of the Friedman 
test, as appropriate.  ICC: excellent (dark gray), good (light gray). Friedman test: reproducible (white).  
166x130mm (300 x 300 DPI)  
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APPENDIX 
 
Stimuli were generated on a 17 inch LG Flatron F700P CRT monitor, 
configured to have a horizontal resolution of 1280 lines and a 72 Hz frame rate, 
driven by a 12-bits video controller (Bits++ , from Cambridge Research 
Systems). The system was colorimetrically characterized and gamma corrected 
using the ColorCAL colorimeter and the Cambridge Research Systems Toolbox 
for MATLAB.  
Observers are initially shown a spatially uniform achromatic field, with 
chromaticity coordinates xCIE=0.2709, yCIE=0.2966 and luminance equal to 45 
cd/m2, covering a 60o-horizontal by 40o-vertical fovea-centred area, and are 
asked to fixate a central 0.5º-wide black cross. The stimuli appearing on this 
background are flickering achromatic, red-green and blue-yellow gratings, with 
Gaussian smoothed borders. Testing points are arranged on a 4x6 regular grid 
–though the four corners of the grid are not tested-, with an additional point at 
the fovea (see Fig. A1a). Not considering the fovea, the grid spacing is 10º and 
the offset from the vertical and horizontal meridians is 5º. The stimulus colour is 
defined by a vector whose components represent the changes in the 
responses, R, in the achromatic (A), red-green (RG) and blue-yellow (BY) 
mechanisms of the opponent modulation space31,32, computed using Brainard’s 
formulation56. If 0R
r
∆  is the vector in this space defining the direction along which 
we are measuring the subject’s threshold and the amplitude of the stimulus at a 
given trial and ( )tyxR ,,
r
∆  is the vector defining the stimulus at each spatial 
location (x,y), measured (in degrees) from the testing point, at instant t (in 
seconds) after stimulus onset, we have: 
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 ( ) ( ) ( ) 




⋅⋅π⋅




 π+π⋅∆=∆
a
y
a
x
rectthtf2rg
2
xf2RtyxR tx0 ,·sinsin,,
rr
 Eq.A.1 
 
where fx and ft are the spatial and temporal frequencies of the stimulus, and “a” 
is the angular size of the window containing the stimulus (5º). The functions g(r) 
and h(t) in Equation A.1 are, respectively, the spatial and the temporal envelope 
of the stimulus and are defined as follows: 
 
 
( )
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
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
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≤≤
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2
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 Eq. A.2 
 
where 222 yxr += ,  r0=1.5
o and σ=(1/3)o; 
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Eq. A.3 
 
where Ts=1 s is the maximum presentation time, t0 equals to 100 ms and 
σt=t0/3. These functions were introduced to smooth spatial-temporal transients 
that may constitute a cue for detection by an undesired mechanism. 
Page 34 of 38
Clinical and Experimental Optometry
Clinical and Experimental Optometry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review
During a measurement session, the direction of vector 0R
r
∆  is fixed and 
coincides with one of the three cardinal directions of the space –that is, the 
direction isolating one of the mechanisms. In Figure A1 we show the limits and 
directions of the colour palettes in the CIE chromaticity diagram (Fig. A1b), and 
examples of the spatial and the temporal profiles (Fig. A1c-d), as well as a 
sample of stimuli in each of the cardinal directions (Fig. A1e-h). 
Insert Figure A1 here 
Stimuli are labelled as “Mechanism (A, RG, or BY)”-“Spatial Frequency 
(0.5 or 4) in cycles per degree (cpd)” /”Temporal Frequency (2 or 12) in Hertz 
(Hz)”. To evaluate the achromatic mechanism, a stimulus favouring the 
magnocellular pathway (A-0.5cpd/12Hz) and another one favouring the 
parvocellular pathway (A-4cpd/2Hz) were chosen43. The red-green and blue-
yellow chromatic mechanisms, putatively mediated by the parvo and 
koniocellular pathways, respectively43, were evaluated with two stimuli of the 
same spatial and temporal frequency (RG-0.5cpd/2Hz and BY-0.5cpd/2Hz). 
The procedure described is similar to the one used by King-Smith for colour 
contrast thresholds, except for the spatial and temporal profile of the 
stimulus57.The stimuli used in this study were chosen after previous 
measurements covering the entire frequency range for each mechanism 
showed that the device had enough dynamic range to determine thresholds of 
subjects up to 70 years old44 and after measurements with pathological subjects 
suggested the possible utility of these stimuli in detection of functional 
damage33,34,58.  
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FIGURE LEGEND 
Figure A1: (a) Array of testing points, (b) RG and BY cardinal directions in the 
colour space used in the experiment (CIE1931). The triangle represents the 
locus of colours generable by the monitor and the thick lines the maximum 
amplitude range available. (c) Spatial profile of a stimulus as shown in the CRT 
monitor. (d) Temporal profile of the stimulus. (e–h) Single frame of each of the 
four stimuli used in the experiment. 
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(a) Array of testing points, (b) RG and BY cardinal directions in the colour space used in the experiment, 
plotted in the CIE1931 color space. The triangle represents the locus of colours generable by the monitor 
and the thick lines the maximum amplitude range available. (c) Spatial profile of a stimulus as shown in the 
CRT monitor. (d) Temporal profile of the stimulus.  
274x227mm (300 x 300 DPI)  
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(e–h) Single frame of each of the four stimuli used in the experiment.  
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